Creative Biolabs is a leading global CRO company that focuses on psychotropic drug development. With our extensive experience and advanced platform, we have won a good reputation among our worldwide customers for accomplishing numerous challenging projects of drug development for psychiatric disorders. We guarantee the finest results for our customers all over the world.
Introduction to Psycho-immunological Marker
Previous studies have shown that immune responses caused by psychiatric disorders can be mediated by various signaling pathways and inflammatory-associated factors. Moreover, recent reports have revealed that changes in the expression level of these factors can be used as specific psycho-immunological markers for treating psychiatric disorders. In the few years of studies, a series of psychotropic drugs have been developed recently for treating different psychiatric disorders, such as post-traumatic stress disorder (PTSD), bipolar disorder (BD), and major depression disease (MDD). Furthermore, a wide variety of psycho-immunological markers, including immunoglobulin-based markers, cytokine based markers, as well as interleukin-based markers, of psychiatric disorders have been validated. They have been widely used for elucidating the pathogenic mechanism and predicting the clinical responses of psychiatric drugs. Biomarkers are a key element for improving the success rate of drug development, thus promoting the discovery of new therapies. Besides, psycho-immunological markers have become a new class of drug development tools in clinical applications.
Psycho-immunological Marker Development Services
Psycho-immunological marker development is a multistep and iterative process, ranging from marker screening to marker evaluation, in disease diagnosis or treatment. An effective psycho-immunological marker of psychiatric disorders can be regarded as an indicator of pathological and immune responses to candidate psychiatric drugs. Creative Biolabs is a world-leading service provider for psychotropic drug development. We are confident in offering top-ranking psycho-immunological marker services for global customers.
Recently, we have generated a well-mature psycho-immunological marker development platform to offer a seamless, high-quality, single-source value chain from discovery to commercialization. Till now, various kinds of psycho-immunological markers, such as lymphokine-based markers, cytokine-based markers, interleukin-based markers, and interferon-based markers, have been identified by our labs to assess the availability of new psychiatric drugs. For instance, aPL (anticardiolipin (ACA)) antibodies have been tested in 93 PTSD patients. The data suggested that the presence of these autoantibodies can be treated as a promising marker for the risk of a psychiatric disorder event.
Why Choose Us?
Our platform equipped with state-of-the-art facilities and highly experienced staff is available to assist in all areas of psycho-immunological marker development studies. We have integrated high-quality services that are based in America and span the entire development chain all over the world. Our company offers the best guarantee in the industry of psycho-immunological marker development and has successfully provided a series of psycho-immunological markers for accelerating new psychiatric drug development.
-
Excellent expert team for offering timely technical support
-
Advanced psycho-immunological marker platforms
-
Cost-effective and efficient services
-
Rapid data feedback to facilitate the process of your project
As a world-leading service provider of psychotropic drug development, Creative Biolabs has accumulated extensive experience from the accomplishment of different projects, during which we have received a lot of recognition and praise from our clients. We are very proud of providing high-quality, omnidirectional psycho-immunological marker development services to our valued clients to remove the difficulties of your projects. For more detailed information, please feel free to contact us or directly sent us an inquiry.
For Research Use Only.
